Hypertrophic pachymeningitis: a rare manifestation of IgG4 related disease

Authors

  • Kumar Sandeepan Department of Medicine, Patna Medical College and Hospital, Patna, Bihar, India
  • Monika Jha Sadar Hospital, Madhepura, Bihar, India
  • Shiv Purari Department of Medicine, Patna Medical College and Hospital, Patna, Bihar, India
  • Pallav K. Sharma Department of Medicine, Patna Medical College and Hospital, Patna, Bihar, India
  • Shreyash . Department of Medicine, Patna Medical College and Hospital, Patna, Bihar, India
  • Chandan Kumar Department of Medicine, Patna Medical College and Hospital, Patna, Bihar, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20232134

Keywords:

Hypertrophic pachymeningitis, IgG4 related disease, CSF IgG4 index, Storiform fibrosis

Abstract

Hypertrophic pachymeningitis (HP) is a rare form of diffuse inflammatory disease that causes thickening of the dura mater. It can involve the cranial or the spinal dura or both. An increasingly well-known symptom of IgG4-related illness, a fibroinflammatory syndrome that may affect almost any organ, is IgG4-related hypertrophic pachymeningitis (IgG4-RHP). It is estimated that IgG4-RHP may account for a high proportion of cases of hypertrophic pachymeningitis once considered idiopathic. Contrast magnetic resonance imaging (MRI) shows pachymeningeal enhancement. Serum IgG4 levels may be elevated but are normal in most patients. However, most patients have elevated cerebrospinal fluid (CSF) IgG4 index. Hence, CSF IgG4 index could serve as a less invasive diagnostic marker of IgG4-RHP. Confirmation of diagnosis is by meningeal biopsy that shows swirling “storiform” fibrosis with lymphocytic infiltrates, obliterate phlebitis and IgG4 positive plasma cells. This case highlights the diagnostic dilemma of IgG4-RHP as gold standard of diagnosis is meningeal biopsy which has many of its own limitations. CSF IgG4 index could be an alternate option for meningeal biopsy when the procedure is contraindicated or uninformative.

References

Karthik SN, Bhanu K, Velayutham S, Jawahar M. Hypertrophic pachymeningitis. Ann Indian Acad Neurol. 2011;14(3):203-4.

Wallace ZS, Carruthers MN, Khosroshahi A, Carruthers R, Shinagare S, Stemmer-Rachamimov A, et al. IgG4-related disease and hypertrophic pachymeningitis. Medicine (Baltimore). 2013;92(4):206-16.

Lu LX, Della-Torre E, Stone JH, Clark SW. IgG4-Related Hypertrophic Pachymeningitis: Clinical Features, Diagnostic Criteria, and Treatment. JAMA Neurol. 2014;71(6):785-93.

Loscalzo J, Fauci A, Kasper D, Hauser S, Longo D, Jameson JL. Harrison’s Principles of internal medicine, 21st edition. McGraw Hill LLC. 2022.

Lu Z, Tongxi L, Jie L, Yujuan J, Wei J, Xia L, Yumin Z, Xin L. IgG4-related spinal pachymeningitis. Clin Rheumatol. 2016;35(6):1549-53.

Lang D, Zwerina J, Pieringer H. IgG4-related disease: current challenges and future prospects. Ther Clin Risk Manag. 2016;12:189-99.

Yu KH, Chan TM, Tsai PH, Chen CH, Chang PY. Diagnostic Performance of Serum IgG4 Levels in Patients With IgG4-Related Disease. Medicine (Baltimore). 2015;94(41):e1707.

Della-Torre E, Galli L, Franciotta D, Bozzolo EP, Briani C, Furlan R, et al. Diagnostic value of IgG4 Indices in IgG4-related hypertrophic pachymeningitis. J Neuroimmunol. 2014;266(1-2):82-6.

Karthik SN, Bhanu K, Velayutham S, Jawahar M. Hypertrophic pachymeningitis. Ann Indian Acad Neurol. 2011;14(3):203-4.

Downloads

Published

2023-06-30

How to Cite

Sandeepan, K., Jha, M., Purari, S., Sharma, P. K., ., S., & Kumar, C. (2023). Hypertrophic pachymeningitis: a rare manifestation of IgG4 related disease. International Journal of Research in Medical Sciences, 11(7), 2732–2735. https://doi.org/10.18203/2320-6012.ijrms20232134

Issue

Section

Case Reports